|
||||||||||||||||||||
|
||||||||||||||
In the past, Altria has focused primarily on maintaining market share in the U.S. Altria is reliant on continued consumption of its products. Decreasing social acceptability of smoking, public awareness of smoking's health risks, and rising costs due to excise taxes and litigation expenses could all lower demand for Altria's products. Litigation also poses a risk to Altria on several fronts: negative press can negatively affect demand, and the costs of with legal battles and settlements are substantial.
Despite the problems that Altria has had to face, its sales continue to grow-its revenue in Q3 2008 increased 5% to $5.2 billion, primarily from higher sales of its Phillip Morris USA cigarette brands.[1] However, the company's net income in the quarter decreased 67% to $867 million because of higher costs associated with its spinoff of its Phillip Morris International segment in March 2008.[1]
Contents |
[edit] History and Corporate Overview
Originally founded in 1847, Altria Group began manufacturing and selling ready-made cigarettes in response to a marked increase in smoking's popularity. Altria entered the U.S. cigarette market in 1902 and has been a dominating force in both the domestic and international tobacco industries ever since. Its flagship brand Marlboro has become the world's most popular cigarette by volume, accounting for an impressive 8.4% of all cigarettes sold around the world. In an effort to concentrate on its tobacco business, Altria has spun off both of former food/beverage companies, Miller Brewing Company (2002), Kraft Foods (2007), and its international tobacco business (Philip Morris International, 2008); however, Altria retains a 28.6% voting interest in SABMiller, the world's second-largest brewer, formed when Altria sold Miller Brewing Company to South African Breweries in 2002.
[edit] Financial Guidance:
Altria (MO):
- 2008 full-year diluted earnings per share from continuing operations were projected in Q1 2008 earnings call to grow approximately 9% to 11% from an adjusted base of $1.50, excluding PMI.
- Long term total annual shareholder return of 12.1% when combined with the dividend.
- EPS growth in the range of 8% to 10%.
- An anticipated dividend payout ratio of 75%, with an initial post-spin annualized dividend rate of $1.16 per share;
- A planned share repurchase program of $7.5 billion over the next two years, which will commence in April of this year;
- Approximately $1.00 billion in cumulative annual cost savings, $300 million of which were realized in 2007 and approximately $700 million in additional savings to be realized by the end of 2011, including cost reductions ($250 million) related to the relocation of corporate headquarters from New York, NY to Richmond, VA.
- Tests in both smokeless and snuffs are going "very well".
Altria Group is composed of two main parts:
[edit] Philip Morris USA
Philip Morris USA (PM USA) is Altria's domestic cigarette manufacturing company. It manages the production and distribution to wholesalers of Altria's U.S.-sold cigarette brands sold, including:
- Marlboro, which accounts for 80% of PM USA's total revenues and 41.5% of all cigarettes sold domestically[1]
- Basic, PM USA's only "discount" brand, which accounts for 8% of the company's total revenues
- Virginia Slims, targeted towards women and accounting for 5% of the company's revenues
- Parliament, which accounts for 3% of the company's revenues
PM USA also manufactures several other brands, which make up about 3% of total revenue and production.
On April 24th, 2008, PM USA's total domestic market share stood at 50.9%, making it the largest tobacco company in the United States by both revenue and volume, and contributing $18.5 billion (25%) to Altria's FY 2007 consolidated revenues.
[edit] Philip Morris Capital Corporation
Philip Morris Capital Corporation (abbreviated as PMCC) is a subsidiary of Altria Group that manages a portfolio of assets, such as aircraft, manufacturing facilities, and real estate, which are leased as a form of investment. The revenues from PMCC, which totaled $220 million in 2007, are used to generate cash flow and operating income for Altria.
| Net Revenues, in millions[2] | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 |
| Domestic Tobacco Net Revenue (PM USA) | 18,877 (24%) | 17,001 (21%) | 17,511 (20%) | 18,134 (19%) | 18,480 (18%) | 18485 (25%) |
| Int\'l Tobacco Net Revenue (PMI) | 28,672 (37%) | 33,389 (41%) | 39,536 (44%) | 45,288 (46%) | 47,897 (48%) | 55096 (75%) |
| North American Food (Kraft Foods) | 21,481 (27%) | 20,937 (26%) | 22,060 (25%) | 23,293 (24%) | 23,107 (23%) | -- |
| Int\'l Food (Kraft Foods Int\'l) | 8,228 (11%) | 9,561 (12%) | 10,108 (11%) | 10,820 (11%) | 10,739 (11%) | -- |
| Financial Services (PMCC) | 495 (<1%) | 432 (<1%) | 395 (<1%) | 319 (<1%) | 273 (<1%) | 220 (<<1%) |
| Total Net Revenues | 80,394 | 81,320 | 89,610 | 97,854 | 100,496 | 73,801 |
Source: Credit Suisse
Note: Kraft Foods was spun off in 2007 and Philip Morris International was spun off in 2008. Future revenues will not include income from this source.
[edit] Trends and Forces
[edit] Diversification into Smokeless Tobacco Diversifies Altria's Revenue Sources
Following the 2007 spin-off of Kraft Foods, Altria now manufactures only tobacco products. Cigarette brands in the United States fall into one of two categories: premium brands and value brands. Currently, 92% of PM USA's revenues come from its premium cigarettes, with Basic, the only value brand, accounting for the other 8%. Internationally, PMI produces and sells over 25 different brands of cigarettes, including both premium and value brands. Marlboro is by and large Altria's largest brand, constituting 40.5% of all cigarette sales in the U.S. and 8.5% of all international sales. Altria's products enjoy significant brand loyalty and very high name recognition. As such, the product line has remained relatively unchanged. In December 2007, Altria completed the acquisition of John Middleton, Inc., a leading manufacturer of machine-made large cigars.
In September 2008, Altria completed the acquistion of UST, the world's largest moist smokeless tobacco manufacturer by sales.[1] UST provides Altria with the leading smokeless tobacco brands, Skoal and Copenhagen.[1] The company's diversification into smokeless tobacco is crucial to promoting its growth- only 21% of U.S. adults smoked cigarettes regularly in 2007, which has declined steadily from its peak of 43% in the 1940s.[3] Conversely, the use of smokeless tobacco is on the rise, with use at about 3% of American adults and 8% of American high school students.[4]
[edit] Economic Downturns
The tobacco industry has proven to be somewhat more resistant to the effects of economic downturns than other industries, perhaps due to the nature of their products or the brand loyalties. Cost-conscious consumers may stop smoking or downgrade to a value-priced brand during economic slumps, but most consume the same brands at the same, or slightly lower, level. As a result, Altria and other similar companies generally experience less of a decrease in revenues during recessions than the economy as a whole.
[edit] Premium vs. Value Brands
As cigarette prices have continued to rise, some consumers have switched from premium brands to value or deep-discount brands. Most of Altria's cigarette brands are classified as premium, making it more sensitive to these shifts in consumption than some other tobacco companies with more equally-distributed product lines. As such, Altria tries to manage the price gap between value and premium cigarettes by keeping their wholesale prices at a level high enough to be profitable but not so high that consumers start switching to value brands.
[edit] Litigation Landscape
The tobacco industry is highly susceptible to litigation. Large, high-profile court cases generate negative publicity and can be very costly for tobacco companies, even before including any damages awarded. Due to its size and significance in the domestic market, Altria is somewhat more likely than other tobacco firms to be targeted in a large lawsuit, increasing its exposure to litigation headline risk relative to that of competitors.
In 2006, however, the litigation outlook improved significantly for U.S. tobacco companies. Three important cases in the industry resulted in victories for Altria and other tobacco companies, leading to a general improvement in the litigation environment. This is a positive factor for Altria, as litigation expenses should be more predictable and stable.
In September 2008, Phillip Morris USA filed suit to overturn a San Fransisco ordinance that bans convenience drugstores from selling tobacco products. The suit alleges the law bans communications directed to adult smokers, violating Altria's constitutional rights. This effort represents Altria's desire to go on the offensive in tobacco litigation. [5]
In December 2008, the US Supreme Court ruled against Phillip Morris USA in a 'light' cigarette case. The decision allows Altria to be sued for deceptive advertising of light cigarettes, which in reality are no healthier than regular cigarettes. [6]
[edit] Decrease in Consumer Demand
The demand for Altria's products is subject to many health and wellness factors, including:
- Public awareness of health risks associated with smoking
- The increase of public awareness about the dangers of smoking cigarettes has led to a decrease in the number of smokers (from roughly 40% of the population in the 1950s to around 20% in the early 2000s).[3] While this factor could still affect future demand for Altria's cigarettes, the likelihood of a significant decrease in consumption due to health concerns is small, since the health risks have been widely known for some time.
- Social acceptability of smoking
- A decrease in the social acceptability of smoking could lead to reduced rates of cigarette consumption. Conversely, a glamorization of smoking could stimulate growth in demand for cigarettes. On the whole, smoking has become somewhat less socially acceptable in the U.S., due to both shifts in cultural attitudes and government regulations on smoking. For some, though, there is still a certain glamorous quality associated with smoking. Cigarettes' social acceptability varies depending on region, however, and many of Altria's other, non-U.S. markets are not as affected by a negative public perception of smoking.
[edit] Government Regulation
Governmental regulations can have a large impact on tobacco companies' revenues and, indirectly, consumer demand. There are two main ways in which governments attempt to regulate the consumption of cigarettes, excise taxes and regulations on smoking in public places.
- Cigarette excise taxes are per-pack taxes placed on cigarettes by governments. They serve two purposes: reducing public cigarette consumption and providing a large source of revenue for treasuries.
- These two reasons put governments, especially state governments in the U.S., in a somewhat difficult position. While many policymakers want to reduce per-capita smoking rates, the excise taxes collected from tobacco companies number in the billions of dollars annually. As a result, governments have a vested interested in the continued viability of Altria and other tobacco companies, making them unwilling allies of the tobacco industry.
- Excise taxes have risen dramatically in the past three decades and are expected to continue upward. Elected officials have realized that the large profitability of the tobacco industry allows individual companies to absorb a significant percentage of an increase in excise taxes without passing the full cost on to consumers. As such, governments can increase revenues from tobacco companies without severely harming demand for the companies' cigarettes.
- Restrictions on cigarette consumption include bans on smoking in public places such as restaurants, workplaces, etc. In the U.S., there has been a recent increase in the number of cities with smoking bans in effect. While having no impact on private consumption of cigarettes, these bans prohibit smoking in many public places, limiting the ability of consumers to choose when and where to smoke.
[edit] Competitors
Altria Group| U.S. Tobacco Companies, 2005 data, in millions | Gross Revenues | Operating Income | Volume, billions of cigarettes | |
|---|---|---|---|---|
| Philip Morris USA | $18,485 | $4,518 | 175.5 | |
| Reynolds American | $8,258 | $1,726 | 107 | |
| Carolina Group | $2,892 | $1,175 | 36.01 | |
Source: Credit Suisse
[edit] References
- ↑ 1.0 1.1 1.2 1.3 1.4 Altria Q3 2008 Press Release 10/23/2008
- ↑ FY 2007 Altria Annual Report
- ↑ 3.0 3.1 "U.S" Smoking Rate Still Coming Down" 7/24/2008
- ↑ "Use of Smokeless Tobacco on the Rise" 7/3/2008
- ↑ MarketWatch Altria unit fights SF law banning tobacco sale in drugstores
- ↑ BloggingStocks, "Altria (MO) slips on Supreme Court ruling"
- ↑ 7.0 7.1 7.2 2007 MO 10-K: Pg 50
- ↑ 2007 MO 10-K: Pg 34
- ↑ 2007 MO 10-K: Pg 77
- ↑ 10.0 10.1 2008 PM 10-12B/A: Pg F-4
- ↑ 2008 PM 10-12B/A, Pg 7
- ↑ 2008 PM 10-12B/A: Pg F-35
- ↑ 13.0 13.1 13.2 2007 RAI 10-K: Pg 59
- ↑ 2007 RAI 10-K: Pg 32
- ↑ 2007 RAI 10-K: Pg 85
- ↑ 16.0 16.1 16.2 2007 VGR 10-K: Pg F-4
- ↑ 2007 VGR 10-K: Pg F-44






